Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
2.450
-0.100 (-3.92%)
Nov 4, 2024, 4:00 PM EST - Market closed

Moleculin Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2015
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2015
Market Capitalization
72930535042
Upgrade
Market Cap Growth
-52.63%-5.48%-42.91%5.47%20.43%48.31%
Upgrade
Enterprise Value
-35-20-223827
Upgrade
Last Close Price
2.4512.8815.9027.9071.7482.36
Upgrade
PE Ratio
--0.85-1.04-3.15-2.71-2.82
Upgrade
PB Ratio
0.351.100.580.672.842.69
Upgrade
P/FCF Ratio
-0.32-1.18-1.10-2.80-2.78-2.43
Upgrade
P/OCF Ratio
-0.32-1.19-1.10-2.80-2.84-2.43
Upgrade
EV/EBITDA Ratio
0.29-0.160.640.96-1.94-1.55
Upgrade
EV/EBIT Ratio
0.29-0.160.640.95-1.92-1.53
Upgrade
EV/FCF Ratio
0.32-0.190.711.15-2.09-1.56
Upgrade
Debt / Equity Ratio
0.030.020.010.000.020.02
Upgrade
Debt / FCF Ratio
-0.02-0.02-0.02-0.01-0.02-0.02
Upgrade
Quick Ratio
1.893.478.9619.595.203.01
Upgrade
Current Ratio
2.393.869.4620.025.893.78
Upgrade
Return on Equity (ROE)
-86.82%-76.07%-44.25%-32.85%-104.14%-88.50%
Upgrade
Return on Assets (ROA)
-47.68%-38.73%-27.06%-25.38%-45.48%-48.87%
Upgrade
Return on Capital (ROIC)
-58.95%-46.71%-29.06%-29.54%-72.61%-72.48%
Upgrade
Earnings Yield
-361.12%-103.79%-95.65%-29.90%-34.44%-31.56%
Upgrade
FCF Yield
-369.43%-84.46%-91.30%-35.69%-36.01%-41.22%
Upgrade
Buyback Yield / Dilution
-16.88%-3.60%-6.43%-172.97%-45.07%-57.20%
Upgrade
Total Shareholder Return
-16.88%-3.60%-6.43%-172.97%-45.07%-57.20%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.